{"title":"Anandamide improves food intake and orexinergic neuronal activity in the chronic sleep deprivation induction model in rats by modulating the expression of the CB1 receptor in the lateral hypothalamus","authors":"Rafie Belali , Seyyed Ali Mard , Seyed Esmaeil Khoshnam , Kowsar Bavarsad , Alireza Sarkaki , Yaghoob Farbood","doi":"10.1016/j.npep.2023.102336","DOIUrl":"10.1016/j.npep.2023.102336","url":null,"abstract":"<div><p><span><span><span>Sleep deprivation alters orexinergic neuronal activity in the lateral </span>hypothalamus (LH), which is the main regulator of sleep-wake, arousal, appetite, and energy regulation processes. </span>Cannabinoid receptor<span><span> (CBR) expression in this area is involved in modulating the function of orexin<span> neurons. In this study, we investigated the effects of endocannabinoid </span></span>anandamide<span> (AEA) administration on improving food intake and appetite by modulating the activity of orexin neurons and CB1R expression after chronic sleep deprivation. Adult male Wistar rats<span><span> (200–250 g) were randomly divided into three groups: control + vehicle (Control), chronic sleep deprivation + vehicle (SD), and chronic sleep deprivation +20 mg/kg AEA (SD + A). For SD induction, the rats were kept in a sleep deprivation device for 18 h (7 a.m. to 1 a.m.) daily for 21 days. Weight gain, food intake, the electrical power of orexin neurons, CB1R mRNA expression in hypothalamus, CB1R protein expression in the LH, TNF-α, IL-6, IL-4 levels and </span>antioxidant activity in hypothalamus were measured after SD induction. Our results showed that AEA administration significantly improved food intake (</span></span></span></span><em>p</em> < 0.01), Electrical activity of orexin neurons (<em>p</em> < 0.05), CB1R expression in the hypothalamus (p < 0.05), and IL-4 levels (<em>p</em> < 0.05). AEA also reduced mRNA expression of OX1R and OX2R (<em>p</em><span> < 0.01 and p < 0.05 respectively), also IL-6 and TNF-α (p < 0.01) and MDA<span><span> level (p < 0.05) in hypothalamic tissue. As a consequence, AEA modulates orexinergic system function and improves food intake by regulating the expression of the </span>CB1 receptor in the LH in sleep deprived rats.</span></span></p></div>","PeriodicalId":19254,"journal":{"name":"Neuropeptides","volume":"101 ","pages":"Article 102336"},"PeriodicalIF":2.9,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10519350","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
NeuropeptidesPub Date : 2023-10-01DOI: 10.1016/j.npep.2023.102350
Li Ren , Hailou Zhang , Weiwei Tao , Wenda Xue , Yin Chen , Zhilu Zou , Xiaoyan Guo , Qinqin Shen , Wei Wang , Haitang Jiang , Juanjuan Tang , Quansheng Feng , Gang Chen
{"title":"Hippocampal pituitary adenylate cyclase–activating polypeptide mediates rapid antidepressant-like effects of Yueju pill","authors":"Li Ren , Hailou Zhang , Weiwei Tao , Wenda Xue , Yin Chen , Zhilu Zou , Xiaoyan Guo , Qinqin Shen , Wei Wang , Haitang Jiang , Juanjuan Tang , Quansheng Feng , Gang Chen","doi":"10.1016/j.npep.2023.102350","DOIUrl":"10.1016/j.npep.2023.102350","url":null,"abstract":"<div><p>Yueju pill, a classic Chinese Medicine formulated, was recently found to produce rapid antidepressant-like effects in a PKA-CREB signaling-dependent manner. In our study, we found that the Yueju pill induced a remarkable increase in PACAP. The intracerebroventricular injection of PACAP agonist induced a rapid antidepressant-like effect; conversely, the intrahippocampal infusion of a PACAP antagonist reversed the antidepressant response of the Yueju pill. Mice with hippocampal PACAP knockdown via viral-mediated RNAi displayed depression-like behavior. PACAP knockdown also blunted the antidepressant effect of the Yueju pill. PACAP knockdown resulted in down-regulated CREB and expression of the synaptic protein PSD95 at both baselines and after administration of the Yueju pill. However, administration of the Yueju pill in the knockdown mice promoted PACAP and PKA levels. Chronically stressed mice showed deficient hippocampal PACAP-PKA-CREB signaling and depression-like behavior, which were reversed by a single dose of the Yueju pill. In this study, we demonstrated that the up-regulation of PACAP induced activating of PKA-CREB signaling would play a part in the rapid antidepressant-like effects of the Yueju pill. We also identified iridoids fraction of <em>Gardenia jasminoides</em> Ellis (GJ-IF), a vital component of the Yueju pill, was identified to recapitulate rapid antidepressant-like behavior through increased hippocampal PACAP expression of the Yueju pill. The promotion of hippocampal PACAP may collectively represent a novel mechanism of rapid antidepressant-like effect.</p></div>","PeriodicalId":19254,"journal":{"name":"Neuropeptides","volume":"101 ","pages":"Article 102350"},"PeriodicalIF":2.9,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10156663","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
NeuropeptidesPub Date : 2023-10-01DOI: 10.1016/j.npep.2023.102352
Roya Kamrani-Sharif , A. Wallace Hayes , Mina Gholami , Mahsa Salehirad , Maryam Allahverdikhani , Majid Motaghinejad , Enzo Emanuele
{"title":"Oxytocin as neuro-hormone and neuro-regulator exert neuroprotective properties: A mechanistic graphical review","authors":"Roya Kamrani-Sharif , A. Wallace Hayes , Mina Gholami , Mahsa Salehirad , Maryam Allahverdikhani , Majid Motaghinejad , Enzo Emanuele","doi":"10.1016/j.npep.2023.102352","DOIUrl":"10.1016/j.npep.2023.102352","url":null,"abstract":"<div><h3>Background</h3><p><span>Neurodegeneration is progressive cell loss in specific neuronal populations, often resulting in clinical consequences with significant medical, societal, and economic implications. Because of its antioxidant, anti-inflammatory, and anti-apoptotic properties, oxytocin has been proposed as a potential </span>neuroprotective and neurobehavioral therapeutic agent, including modulating mood disturbances and cognitive enchantment.</p></div><div><h3>Methods</h3><p><span>Literature searches were conducted using the following databases Web of Science, PubMed, Elsevier Science Direct, Google Scholar, the Core Collection, and Cochrane from January 2000 to February 2023 for articles dealing with oxytocin neuroprotective properties in preventing or treating neurodegenerative disorders and diseases with a focus on </span>oxidative stress, inflammation, and apoptosis/cell death.</p></div><div><h3>Results</h3><p><span><span>The neuroprotective effects of oxytocin appears to be mediated by its anti-inflammatory properties, inhibition of neuro inflammation, activation of several antioxidant enzymes, inhibition of oxidative stress and </span>free radical formation, activation of free radical scavengers, prevent of mitochondrial dysfunction, and inhibition of </span>apoptosis.</p></div><div><h3>Conclusion</h3><p>Oxytocin acts as a neuroprotective agent by preventing neuro-apoptosis, neuro-inflammation, and neuronal oxidative stress, and by restoring mitochondrial function.</p></div>","PeriodicalId":19254,"journal":{"name":"Neuropeptides","volume":"101 ","pages":"Article 102352"},"PeriodicalIF":2.9,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10163227","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
NeuropeptidesPub Date : 2023-10-01DOI: 10.1016/j.npep.2023.102355
Hong-mei Luo , Jia-rong Ye , Fan-qin Pu , Hong-liang Luo , Wen-jun Zhang
{"title":"Role and therapeutic target of P2X2/3 receptors in visceral pain","authors":"Hong-mei Luo , Jia-rong Ye , Fan-qin Pu , Hong-liang Luo , Wen-jun Zhang","doi":"10.1016/j.npep.2023.102355","DOIUrl":"10.1016/j.npep.2023.102355","url":null,"abstract":"<div><p>Visceral pain<span> (VP) is caused by internal organ disease. VP is involved in nerve conduction<span> and related signaling molecules, but its specific pathogenesis has not yet been fully elucidated. Currently, there are no effective methods for treating VP. The role of P2X2/3 in VP has progressed. After visceral organs are subjected to noxious stimulation<span>, cells release ATP, activate P2X2/3, enhance the sensitivity of peripheral receptors and the plasticity of neurons, enhance sensory information transmission, sensitize the central nervous system<span>, and play an important role in the development of VP. However, antagonists possess the pharmacological effect of relieving pain. Therefore, in this review, we summarize the biological functions of P2X2/3 and discuss the intrinsic link between P2X2/3 and VP. Moreover, we focus on the pharmacological effects of P2X2/3 antagonists on VP therapy and provide a theoretical basis for its targeted therapy.</span></span></span></span></p></div>","PeriodicalId":19254,"journal":{"name":"Neuropeptides","volume":"101 ","pages":"Article 102355"},"PeriodicalIF":2.9,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10168556","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
NeuropeptidesPub Date : 2023-10-01DOI: 10.1016/j.npep.2023.102368
Esraa K. Aly , Hanan S. Mahmoud , Dalal Hussien M. Alkhalifah , Gaber M.G. Shehab , Abdelaziz S.A. Abuelsaad , Eman S. Abdel-Rehiem , Manal Abdul-Hamid
{"title":"Bee venom ameliorates oxidative stress and histopathological changes of hippocampus, liver and testis during status epileptics","authors":"Esraa K. Aly , Hanan S. Mahmoud , Dalal Hussien M. Alkhalifah , Gaber M.G. Shehab , Abdelaziz S.A. Abuelsaad , Eman S. Abdel-Rehiem , Manal Abdul-Hamid","doi":"10.1016/j.npep.2023.102368","DOIUrl":"10.1016/j.npep.2023.102368","url":null,"abstract":"<div><p><span><span><span>The unrelenting progression of neurodegenerative diseases<span><span> has a negative impact on affected individuals, their families, and society. Recurrent epileptic seizures are the hallmark of epilepsy, and treating it effectively remains difficult. Clarify and understanding effects of the </span>antiepileptic drugs<span><span><span> (AEDs) in epilepsy by comparing the therapeutic effects between rats receiving valproic acid (VPA) and </span>Bee venom<span> (BV) was aimed throughout the present study. Four male Wistar rat<span> groups were included: control, epileptic group receiving pilocarpine<span> (PILO), epileptic group treated with VPA and BV respectively. Cognitive functions were assessed by evaluating latency time in hot plate, </span></span></span></span>despair<span> swim test, grooming, rearing and ambulation frequency in the open field. BV has ameliorative effect on electrolytes balancing, assured by decreasing lipid peroxidation<span><span>, nitric oxide and increasing </span>catalase, </span></span></span></span></span>superoxide dismutase and </span>glutathione peroxidase<span><span> activities. BV enhanced restoration of liver functions indicated by alanine transaminase (ALT) and </span>aspartate transaminase (AST), total proteins, and albumin; hormonal parameters total and </span></span>free testosterone<span><span>, follicle stimulating hormone<span> (FSH) and Luteinizing hormone<span> (LH) were preserved by BV with great recovery of hippocampus, liver and testicular </span></span></span>histopathology<span> and ultrastructure comparing with the epileptic rats. The present findings suggested that BV and its active components offer fresh options for controlling epilepsy and prospective methods via minimize or manage the severe consequences.</span></span></p></div>","PeriodicalId":19254,"journal":{"name":"Neuropeptides","volume":"101 ","pages":"Article 102368"},"PeriodicalIF":2.9,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10520891","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
NeuropeptidesPub Date : 2023-10-01DOI: 10.1016/j.npep.2023.102367
Arzuhan Cetindag Ciltas , Sebahattin Karabulut , Bilal Sahin , Ahmet Kemal Filiz , Fatih Yulak , Mustafa Ozkaraca , Ozhan Karatas , Ali Cetin
{"title":"FGF-18 alleviates memory impairments and neuropathological changes in a rat model of Alzheimer's disease","authors":"Arzuhan Cetindag Ciltas , Sebahattin Karabulut , Bilal Sahin , Ahmet Kemal Filiz , Fatih Yulak , Mustafa Ozkaraca , Ozhan Karatas , Ali Cetin","doi":"10.1016/j.npep.2023.102367","DOIUrl":"10.1016/j.npep.2023.102367","url":null,"abstract":"<div><p><span><span>Alzheimer's disease (AD) is a multifactorial pathology marked by </span>amyloid beta<span><span> (Aβ) accumulation, tau hyperphosphorylation, and progressive cognitive decline. Previous studies show that </span>fibroblast growth factor 18<span> (FGF18) exerts a neuroprotective<span> effect in experimental models of neurodegeneration; however, how it affects AD pathology remains unknown. This study aimed to ascertain the impact of FGF18 on the behavioral and neuropathological changes in the rat model of sporadic AD induced by intracerebroventricular (ICV) injection of </span></span></span></span>streptozotocin<span><span> (STZ). The rats were treated with FGF18 (0.94 and 1.88 pmol, ICV) on the 15th day after STZ injection. Their cognitive function was assessed in the Morris water maze and </span>passive avoidance<span><span><span> tests for 5 days from the 16th to the 21st days. Aβ levels and histological signs of neurotoxicity were detected using the enzyme-linked immunosorbent assay (ELISA) assay and histopathological analysis of the brain, respectively. FGF18 mildly ameliorated the STZ-induced </span>cognitive impairment; the Aβ accumulation was reduced; and the neuronal damage including </span>pyknosis<span> and apoptosis was alleviated in the rat brain. This study highlights the promising therapeutic potential for FGF18 in managing AD.</span></span></span></p></div>","PeriodicalId":19254,"journal":{"name":"Neuropeptides","volume":"101 ","pages":"Article 102367"},"PeriodicalIF":2.9,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10164331","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
NeuropeptidesPub Date : 2023-10-01DOI: 10.1016/j.npep.2023.102351
Jiawei Fu , Chunshuai Wu , Guanhua Xu , Jinlong Zhang , Jiajia Chen , Chu Chen , Hongxiang Hong , Pengfei Xue , Jiawei Jiang , Jiayi Huang , Chunyan Ji , Zhiming Cui
{"title":"Protective effect of TNIP2 on the inflammatory response of microglia after spinal cord injury in rats","authors":"Jiawei Fu , Chunshuai Wu , Guanhua Xu , Jinlong Zhang , Jiajia Chen , Chu Chen , Hongxiang Hong , Pengfei Xue , Jiawei Jiang , Jiayi Huang , Chunyan Ji , Zhiming Cui","doi":"10.1016/j.npep.2023.102351","DOIUrl":"10.1016/j.npep.2023.102351","url":null,"abstract":"<div><h3>Background</h3><p>Spinal cord injury<span> (SCI) is a devastating disease that can lead to tissue loss and neurological dysfunction. TNIP2 is a negative regulator of NF-κB signaling due to its capacity to bind A20 and suppress inflammatory cytokines-induced NF-κB activation. However, the anti-inflammatory role of TNIP2 in SCI remains unclear. Our study's intention was to evaluate the effect of TNIP2 on the inflammatory response of microglia after spinal cord injury in rats.</span></p></div><div><h3>Methods</h3><p><span><span>HE </span>staining<span> and Nissl staining were performed on day 3 following SCI to analyze the histological changes. To further investigate the functional changes of TNIP2 after SCI, we performed immunofluorescence staining experiments. The effect of </span></span>LPS<span> on TNIP2 expression in BV2 cells was examined by western blot. The levels of TNF-α, IL-1β, and IL-6 in spinal cord tissues of rats with SCI and in BV2 cells with LPS were measured by using qPCR.</span></p></div><div><h3>Results</h3><p><span>TNIP2 expression was closely associated with the pathophysiology of SCI in rats, and TNIP2 was involved in regulating functional changes in microglia. TNIP2 expression was increased during SCI in rats and that overexpression of TNIP2 inhibited M1 polarization and pro-inflammatory cytokine production in microglia, which might ultimately protect against inflammatory responses through the </span>MAPK<span> and NF-κB signaling pathways.</span></p></div><div><h3>Conclusions</h3><p>The present study provides evidence for a role of TNIP2 in the regulation of inflammation in SCI and suggests that induction of TNIP2 expression alleviated the inflammatory response of microglia.</p></div>","PeriodicalId":19254,"journal":{"name":"Neuropeptides","volume":"101 ","pages":"Article 102351"},"PeriodicalIF":2.9,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10249146","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
NeuropeptidesPub Date : 2023-10-01DOI: 10.1016/j.npep.2023.102353
Sajad Mazaheri , Morteza Zendehdel , Abbas Haghparast
{"title":"Restraint stress potentiates sensitivity to the antinociceptive effect of morphine through orexin receptors in the ventral tegmental area","authors":"Sajad Mazaheri , Morteza Zendehdel , Abbas Haghparast","doi":"10.1016/j.npep.2023.102353","DOIUrl":"10.1016/j.npep.2023.102353","url":null,"abstract":"<div><p><span><span>Orexin<span> signaling in the ventral tegmental area (VTA) plays a critical role in stress and </span></span>addictive behaviors<span>. On the other hand, exposure to stress potentiates behavioral sensitization to drugs<span> of abuse such as morphine. This study aimed to elucidate the role of orexin receptors within the VTA in restraint stress (</span></span></span><em>RS</em><span><span>)-induced morphine sensitization. Adult male albino Wistar rats underwent </span>stereotaxic surgery<span>, and two stainless steel guide cannulae<span> were bilaterally implanted into the VTA. Different doses of SB334867<span> or TCS OX2 29 as orexin-1 (OX1) and orexin-2 (OX2) receptor antagonists were microinjected into the VTA five min before exposure to RS, respectively. A duration of three hours was considered for applying the RS, and 10 min after RS exposure, animals received a subcutaneous injection of an ineffective dose of morphine (1 mg/kg) for three consecutive days followed by a five-day drug/stress-free period. On the ninth day, the tail-flick test evaluated the sensitivity to the antinociceptive effects of morphine. The results demonstrated that the sole application of RS or morphine (1 mg/kg) could not induce morphine sensitization; however, concurrent application of RS and morphine could induce morphine sensitization. Besides, intra-VTA administration of OX1 R or OX2 R antagonists before paired administration of morphine and RS blocked morphine sensitization. The role of OX1 R and OX2 R in the induction of stress-induced morphine sensitization was almost identical. This study provides new insight into the role of orexin signaling in the VTA in the potentiation of morphine sensitization induced by RS and morphine co-administration.</span></span></span></span></p></div>","PeriodicalId":19254,"journal":{"name":"Neuropeptides","volume":"101 ","pages":"Article 102353"},"PeriodicalIF":2.9,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10165769","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Neurobiochemical characteristics of arginine-rich peptides explain their potential therapeutic efficacy in neurodegenerative diseases","authors":"Sedigheh Eskandari , Ameneh Rezayof , S. Mohsen Asghari , Shiva Hashemizadeh","doi":"10.1016/j.npep.2023.102356","DOIUrl":"10.1016/j.npep.2023.102356","url":null,"abstract":"<div><p><span>Neurodegenerative diseases<span><span>, including Alzheimer̕ s disease (AD), Parkinson̕ s disease (PD), Huntington̕ s disease (HD), and Amyotrophic Lateral Sclerosis (ALS) require special attention to find new potential </span>treatment<span> methods. This review aims to summarize the current knowledge of the relationship between the biochemical properties of arginine-rich peptides (ARPs) and their neuroprotective effects to deal with the harmful effects of risk factors. It seems that ARPs have portrayed a promising and fantastic landscape for treating neurodegeneration-associated disorders. With multimodal mechanisms of action, ARPs play various unprecedented roles, including as the novel delivery platforms for entering the </span></span></span>central nervous system<span><span><span> (CNS), the potent antagonists for calcium influx<span>, the invader molecules for targeting mitochondria, and the protein stabilizers. Interestingly, these peptides inhibit the proteolytic enzymes<span> and block protein aggregation to induce pro-survival signaling pathways. ARPs also serve as the scavengers of toxic molecules and the reducers of </span></span></span>oxidative stress<span><span> agents. They also have anti-inflammatory, antimicrobial, and anti-cancer properties. Moreover, by providing an efficient </span>nucleic acid delivery system, ARPs can play an essential role in developing various fields, including gene vaccines, gene therapy, gene editing, and imaging. ARP agents and ARP/cargo therapeutics can be raised as an emergent class of neurotherapeutics for </span></span>neurodegeneration<span>. Part of the aim of this review is to present recent advances in treating neurodegenerative diseases using ARPs as an emerging and powerful therapeutic tool. The applications and progress of ARPs-based nucleic acid delivery systems have also been discussed to highlight their usefulness as a broad-acting class of drugs.</span></span></p></div>","PeriodicalId":19254,"journal":{"name":"Neuropeptides","volume":"101 ","pages":"Article 102356"},"PeriodicalIF":2.9,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10168557","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
NeuropeptidesPub Date : 2023-10-01DOI: 10.1016/j.npep.2023.102357
Forouzan Rafie , Mohammad Amin Rajizadeh , Mehdi Shahbazi , Mohammad Pourranjbar , Amir H. Nekouei , Vahid Sheibani , Daniel Peterson
{"title":"Effects of voluntary, and forced exercises on neurotrophic factors and cognitive function in animal models of Parkinson's disease","authors":"Forouzan Rafie , Mohammad Amin Rajizadeh , Mehdi Shahbazi , Mohammad Pourranjbar , Amir H. Nekouei , Vahid Sheibani , Daniel Peterson","doi":"10.1016/j.npep.2023.102357","DOIUrl":"10.1016/j.npep.2023.102357","url":null,"abstract":"<div><h3>Background</h3><p><span>Parkinson's disease<span> (PD) is one of the most common neurodegenerative diseases in the elderly. </span></span>Cognitive dysfunction<span> represents a common and challenging non-motor symptom for people with Parkinson's disease. The number of neurotrophic proteins in the brain is critical in neurodegenerative diseases such as Parkinson's. This research aims to compare the effects of two types of exercise, forced and voluntary, on spatial memory and learning and neurochemical factors (CDNF and BDNF).</span></p></div><div><h3>Methods</h3><p>In this research, 60 male rats were randomly divided into six groups (<em>n</em><span><span> = 10): the control (CTL) group without exercise, the Parkinson's groups without and with forced (FE) and voluntary (VE) exercises, and the sham groups (with voluntary and forced exercise). The animals in the forced exercise group were placed on the treadmill for four weeks (five days a week). At the same time, voluntary exercise training groups were placed in a special cage equipped with a rotating wheel. At the end of 4 weeks, learning and spatial memory were evaluated with the Morris water maze<span> test. BDNF and CDNF protein levels in the </span></span>hippocampus<span> were measured by the ELISA method.</span></span></p></div><div><h3>Results</h3><p>The results showed that although the PD group without exercise was at a significantly lower level than other groups in terms of cognitive function and neurochemical factors, both types of exercise, could improve these problems.</p></div><div><h3>Conclusion</h3><p>According to our results, 4 weeks of voluntary and forced exercises were all found to reverse the cognitive impairments of PD rats.</p></div>","PeriodicalId":19254,"journal":{"name":"Neuropeptides","volume":"101 ","pages":"Article 102357"},"PeriodicalIF":2.9,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10537783","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}